Balchem Corporation (BCPC)
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
$171.61-0.08%
Close 2026-09-04 · 1-day change
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · BCPC
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 1,085.9 | 1,037.2 | 953.7 | 922.4 | 942.4 | 799.0 | 703.6 | 643.7 | 643.7 | 594.8 | 553.2 | 552.5 | 541.4 | 337.2 | 310.4 | 291.9 |
| Total Revenues | — | — | — | — | — | 799.0 | 703.6 | 643.7 | 643.7 | 594.8 | 553.2 | 552.5 | 541.4 | 337.2 | 310.4 | 291.9 |
| Cost of Revenues | 691.8 | 666.5 | 617.5 | 620.4 | 661.9 | 555.8 | 479.7 | 432.3 | 439.4 | 405.8 | 372.3 | 384.4 | 397.2 | 239.8 | 220.9 | 205.9 |
| Gross Profit | 394.1 | 370.6 | 336.2 | 302.1 | 280.5 | 243.2 | 223.9 | 211.4 | 204.3 | 189.0 | 180.9 | 168.1 | 144.2 | 97.4 | 89.5 | 86.0 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | — | — | — | — | — | — | — | — | — | — | — | 2.9 | 2.9 | — | — | — |
| R&D Expenses | 20.0 | 18.5 | 16.8 | 15.0 | 12.2 | 13.5 | 10.3 | 11.4 | 11.6 | 9.3 | 7.3 | 6.0 | 4.8 | 3.6 | 3.4 | 2.9 |
| Operating Income | 219.5 | 209.3 | 182.9 | 159.2 | 145.2 | 127.5 | 111.1 | 102.6 | 107.1 | 96.9 | 90.8 | 94.0 | 82.1 | 65.6 | 59.8 | 56.2 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | 7.5 | 7.3 | 6.6 | 5.1 | 0.0 | 0.0 | 0.1 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.0 | 0.2 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | 7.5 | 7.3 | 6.6 | 5.1 | (0.3) | 0.0 | (0.1) |
| Other Non-Operating Income / Expenses | (9.3) | (10.3) | (16.5) | (21.9) | (11.4) | (2.3) | (4.7) | (6.1) | — | (8.4) | (7.9) | (6.9) | (5.1) | 0.2 | 0.1 | 0.5 |
| Asset Writedown | — | — | — | 7.8 | 0.0 | 1.7 | 1.9 | 1.1 | 1.8 | 0.0 | 0.0 | 0.3 | 0.2 | 0.0 | 0.0 | 0.1 |
| EBT, Incl. Unusual Items | 212.4 | 199.0 | 166.5 | 137.3 | 133.7 | 125.2 | 106.4 | 96.5 | 99.0 | 88.5 | 82.9 | 87.1 | 77.1 | 65.8 | 59.8 | 56.7 |
| Income Tax Expense | 48.0 | 44.2 | 38.0 | 28.7 | 28.4 | 29.1 | 21.8 | 16.8 | 20.5 | (1.6) | 27.0 | 27.3 | 24.2 | 20.9 | 19.8 | 18.0 |
| Net Income | ||||||||||||||||
| Net Income | 164.4 | 154.8 | 128.5 | 108.5 | 105.4 | 96.1 | 84.6 | 79.7 | 78.6 | 90.1 | 56.0 | 59.7 | 52.8 | 44.9 | 40.0 | 38.8 |
| Per Share | ||||||||||||||||
| Basic EPS | 5.15 | 4.80 | 3.97 | 3.38 | 3.29 | 2.98 | 2.63 | 2.48 | 2.45 | 2.83 | 1.78 | 1.92 | 1.74 | 1.51 | 1.38 | 1.36 |
| Diluted EPS | 5.11 | 4.75 | 3.93 | 3.35 | 3.25 | 2.94 | 2.60 | 2.45 | 2.42 | 2.79 | 1.75 | 1.89 | 1.69 | 1.45 | 1.32 | 1.28 |
| Revenue per Share | 33.72 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | 0.96 | 0.87 | 0.79 | 0.71 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 31.9 | 32.3 | 32.3 | 32.1 | 32.0 | 32.2 | 32.2 | 32.1 | 32.1 | 31.8 | 31.5 | 31.2 | 30.4 | 29.6 | 29.0 | 28.6 |
| Diluted Weighted Avg Shares | 32.2 | 32.6 | 32.7 | 32.4 | 32.4 | 32.7 | 32.5 | 32.5 | 32.4 | 32.2 | 31.9 | 31.6 | 31.2 | 30.8 | 30.4 | 30.2 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 255.0 | 230.9 | 214.1 | 197.0 | 176.4 | 162.4 | 148.4 | 151.8 | 141.3 | 137.0 | 133.9 | 112.7 | 76.1 | 69.4 | 65.5 |
| EBIT | 219.5 | 209.3 | 182.9 | 159.2 | 145.2 | 127.5 | 111.1 | 102.6 | 107.1 | 96.9 | 90.8 | 94.0 | 82.1 | 65.6 | 59.8 | 56.2 |
| Effective Tax Rate | 22.6% | — | — | 20.9% | 21.2% | 23.3% | 20.5% | 17.4% | 20.7% | -1.8% | 32.5% | 31.4% | 31.4% | 31.8% | 33.2% | 31.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.